Skip to content
Glenmark Pharmaceuticals
Global
Menu
Close
Global
US
India
Europe
Latin America
ROW
Asia
Malaysia
Australia
Me & Africa
Russia & CIS
Global
US
India
Europe
Latin America
ROW
Asia
Malaysia
Australia
Me & Africa
Russia & CIS
Connect with Us
Global Presence
Contact Us
Global Presence
Contact Us
Be a part of our
global growth story
To improve patient lives
About us
Our Journey
Board of Directors
Leadership
Governance
Manufacturing
R&D
Innovation
Overview
Pipeline
Partnership
Products
Portfolio
Top Products
Responsibility
Corporate Social Responsibility
Sustainability
Investors
Financials
Disclosures under Regulation 46 of SEBI LODR
Investor Resources
Other announcements
News
Press Release
Media Library
Careers
Life at Glenmark
Glenmark Centre for Learning
Join Us
Toggle website search
Subsidiary Financials FY24-25
Menu
Close
Quarter Results
Investor Presentation
Annual Report
Quarter Results
Investor Presentation
Annual Report
Glenmark Healthcare Limited
Glenmark Pharmaceuticals FZE
Glenmark Pharmaceuticals (Australia) Pty Ltd
GLENMARK PHARMACEUTICALS ECUADOR S.A.
GLENMARK PHARMACEUTICAL SPA
Glenmark Pharmaceuticals Egypt S.A.E.
Glenmark Philippines Inc.
Subsidiary Financials
Menu
Close
2024 -25
2023 -24
2022 -23
2021 -22
2024 -25
2023 -24
2022 -23
2021 -22